This article has been cited by other articles in PMC.
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (355K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
These references are in PubMed. This may not be the complete list of references from this article.
Anderson JN, Peck EJ, Jr, Clark JH. Estrogen-induced uterine responses and growth: relationship to receptor estrogen binding by uterine nuclei. Endocrinology. 1975 Jan;96(1):160–167.[PubMed]
Gordon J, Reagan JW, Finkle WD, Ziel HK. Estrogen and endometrial carcinoma. An independent pathology review supporting original risk estimate. N Engl J Med. 1977 Sep 15;297(11):570–571.[PubMed]
Gurpide E, Gusberg SB, Tseng L. Estradiol binding and metabolism in human endometrial hyperplasia and adenocarcinoma. J Steroid Biochem. 1976 Nov-Dec;7(11-12):891–896.[PubMed]
Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol. 1979 Mar 1;133(5):537–547.[PubMed]
Jick H, Watkins RN, Hunter JR, Dinan BJ, Madsen S, Rothman KJ, Walker AM. Replacement estrogens and endometrial cancer. N Engl J Med. 1979 Feb 1;300(5):218–222.[PubMed]
Rigg LA, Hermann H, Yen SS. Absorption of estrogens from vaginal creams. N Engl J Med. 1978 Jan 26;298(4):195–197.[PubMed]
Thom MH, White PJ, Williams RM, Sturdee DW, Paterson ME, Wade-Evans T, Studd JW. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. Lancet. 1979 Sep 1;2(8140):455–457.[PubMed]
Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press